Stockreport

Achilles Therapeutics Announces Strategic Update

Achilles Therapeutics plc - American Depositary Shares  (ACHL) 
PDF –Achilles to discontinue development of TIL-based cNeT therapy– –Cash position of $95.1 million as of June 30, 2024– –BofA Securities engaged to provide strategic fina [Read more]